<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>17680243</Do_id>
  <Journal>Cancer chemotherapy and pharmacology</Journal>
  <Doc_title>Dermatitis after suspected imatinib-levothyroxine interaction in a patient with gastrointestinal stromal tumor.</Doc_title>
  <Doc_abstract>None</Doc_abstract>
  <Doc_ChemicalList>Antineoplastic Agents;Benzamides;Piperazines;Pyrimidines;Imatinib Mesylate;Protein-Tyrosine Kinases;Thyroxine</Doc_ChemicalList>
  <Doc_meshdescriptors>Aged;Antineoplastic Agents;Benzamides;Drug Eruptions;Gastrointestinal Stromal Tumors;Humans;Imatinib Mesylate;Male;Piperazines;Protein-Tyrosine Kinases;Pyrimidines;Skin;Thyroxine</Doc_meshdescriptors>
  <Doc_meshqualifiers>administration &amp; dosage;adverse effects;pathology;complications;pathology;administration &amp; dosage;adverse effects;antagonists &amp; inhibitors;administration &amp; dosage;adverse effects;pathology;administration &amp; dosage;adverse effects</Doc_meshqualifiers>
</Document>
